Table 1.
Baseline demographic and clinical characteristics of patients between different outcome groups.
| Characteristic | Functional independence | Non-functional independence | p | No intracranial hemorrhage | Intracranial hemorrhage | p | Mortality | Survival | p |
|---|---|---|---|---|---|---|---|---|---|
| Demographic | |||||||||
| Age, years | 63.00 (52.00–69.00) | 64.00 (55.00–70.00) | 0.164 | 62.00 (53.00–69.00) | 65.00 (56.00–71.00) | 0.015 | 65.0 (56.00–72.20) | 63.0 (54.00–69.00) | 0.156 |
| Gender [Men, n (%)] | 176 (73.6) | 220 (66.9) | 0.083 | 291 (73.1) | 105 (61.8) | 0.007 | 37 (57.8) | 359 (71.2) | 0.040 |
| Vascular risk factors | |||||||||
| Hypertension, n (%) | 129 (54.0) | 203 (61.7) | 0.065 | 236 (59.3) | 96 (56.5) | 0.531 | 42 (65.6) | 290 (57.5) | 0.271 |
| Diabetes, n (%) | 50 (20.9) | 95 (28.9) | 0.032 | 98 (24.6) | 47 (27.6) | 0.449 | 18 (28.1) | 127 (25.2) | 0.724 |
| Atrial fibrillation, n (%) | 44 (18.4) | 63 (19.1) | 0.824 | 61 (15.3) | 46 (27.1) | 0.001 | 16 (25.0) | 91 (18.1) | 0.243 |
| Process measures | |||||||||
| Time from onset to arterial puncture, min | 360.00 (240.00–662.00) | 395.00 (250.00–700.00) | 0.212 | 373.50 (235.00–695.50) | 381.50 (265.00–630.00) | 0.579 | 337.00 (234.00–511.00) | 380.00 (250.00–698.00) | 0.233 |
| Time from arterial puncture to reperfusion or procedure completion, min | 70.00 (50.00–100.00) | 85.00 (60.00–118.50) | <0.001 | 75.00 (50.00–105.00) | 85.00 (65.00–120.00) | <0.001 | 96.00 (70.80–135.00) | 75.00 (55.00–105.00) | <0.001 |
| TOAST, n (%) | 0.193 | 0.001* | 0.582* | ||||||
| LAA | 117 (49.0) | 177 (53.8) | 217 (54.5) | 77 (45.3) | 31 (48.4) | 263 (52.2) | |||
| CE | 57 (23.8) | 63 (19.1) | 69 (17.3) | 51 (30.0) | 16 (25.0) | 104 (20.6) | |||
| SAO | 4 (1.7) | 8 (2.4) | 12 (3.0) | 0 (0.0) | 0 (0.00) | 12 (2.38) | |||
| ODC | 11 (4.6) | 26 (7.9) | 23 (5.8) | 14 (8.2) | 6 (9.38) | 31 (6.15) | |||
| UE | 50 (20.9) | 55 (16.7) | 77 (19.3) | 28 (16.5) | 11 (17.2) | 94 (18.7) | |||
| Intravenous thrombolysis, n (%) | 30 (12.6) | 37 (11.2) | 0.634 | 47 (11.8) | 20 (11.8) | 0.988 | 7 (10.9) | 60 (11.9) | 0.984 |
| eTICI≥2b, n (%) | 214 (89.5) | 252 (76.6) | <0.001 | 334 (83.9) | 132 (77.6) | 0.074 | 43 (67.2) | 423 (83.9) | 0.002 |
| Baseline total NIHSS score | 11.00 (9.00–14.00) | 13.00 (11.00–16.00) | <0.001 | 12.00 (9.00–15.00) | 13.00 (11.00–16.00) | 0.010 | 16.00 (13.00–19.00) | 12.00 (9.75–15.00) | <0.001 |
| Baseline ASPECTS score | 10.00 (8.00–10.00) | 9.00 (7.00–10.00) | <0.001 | 9.00 (8.00–10.00) | 9.00 (7.00–10.00) | <0.001 | 9.00 (7.00–10.00) | 9.00 (8.00–10.00) | 0.053 |
ASPECTS, Alberta Stroke Program Early CT Score; eTICI, expanded Treatment in Cerebral Ischemia; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage; TOAST, trial of org 10,172 in acute stroke treatment; LAA, large artery atherosclerosis; SAO, small artery occlusion; CE, cardioembolism; ODC, other determined cause; UE, undetermined etiology. *, Fisher’s precise test.